Search Results - Michelle Turner
- Showing 1 - 12 results of 12
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Perinatal outcomes following nonadherence to guideline‐based screening for gestational diabetes: A population‐based cohort study by Elizabeth Nethery, Kelly Pickerill, Luba Butska, Michelle Turner, Jennifer A. Hutcheon, Patricia A. Janssen, Laura Schummers
Published in Acta Obstetricia et Gynecologica Scandinavica (2025-05-01)Get full text
Article -
8
-
9
Advancing access to substance use prevention for foster youth through digital innovation: an open trial of fostrspace with court appointed special advocate programs by Marina Tolou-Shams, Johanna B. Folk, Margareth V. Del Cid, Jannet Lara Salas, Alison Czopp, Juan Carlos Gonzalez, Tylia Lundberg, Erin Michelle Turner Kerrison, Martha Shumway, Ann Wrixon, Robert Salgado, Jill Duerr Berrick
Published in BMC Health Services Research (2025-05-01)Get full text
Article -
10
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology by Laura C Cappelli, Maria E Suarez-Almazor, Michelle Turner, Stephane Champiat, Caroline Robert, Julie R Brahmer, Jarushka Naidoo, Jeffrey Weber, Joanne Riemer, Elad Sharon, Michael B Atkins, M Catherine Pietanza, Karthik Suresh, Catherine Murphy, Javid Moslehi, David Feltquate, Lee M Krug
Published in Journal for ImmunoTherapy of Cancer (2023-03-01)Get full text
Article -
11
An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis by Kai-li Liang, Sean Tackett, Samantha Myers, Julie R. Brahmer, Ilene S. Browner, David S. Ettinger, Patrick M. Forde, Russell K. Hales, Christine L. Hann, Vincent K. Lam, Kristen A. Marrone, Tricia Patel, Valerie Peterson, Sarah Sagorsky, Michelle Turner, Khinh R. Voong, Jarushka Naidoo, Josephine L. Feliciano
Published in Current Oncology (2022-06-01)Get full text
Article -
12
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events by Rajeev Sharma, Laura C Cappelli, Michelle Turner, Julie R Brahmer, Jarushka Naidoo, Paolo Antonio Ascierto, Igor Puzanov, Hamzah Abu-Sbeih, Jeffrey A Sosman, Marc S Ernstoff, Jill Brufsky, Mario E Lacouture, Douglas B Johnson, Lamya Hamad, Miguel-Angel Perales, Eric Hansen, David E Gerber, Frank B Cortazar, Gregory A Masters, Michele Nanni, Satish P Shanbhag, Dimitra Skondra
Published in Journal for ImmunoTherapy of Cancer (2021-06-01)Get full text
Article
